Bitget App
スマートな取引を実現
暗号資産を購入市場取引先物Bitget Earn広場もっと見る

DRUG stock price forecast

How will DRUG stock perform in 2026 and 2030?

This page primarily displays the projected price range for DRUG stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of DRUG, the development trends of Bright Minds Biosciences Inc., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for DRUG. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Bright Minds Biosciences Inc.'s financial performance and industry trends to provide short-term price predictions for DRUG stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year DRUG stock price forecast

Price target:
135.8 CAD
+24.98%
Based on 1-year price forecasts from 87 analysts, the highest estimate is 153.19 CAD, while the lowest estimate is 101.73 CAD.

Analyst rating for DRUG

Based on ratings from 45 analysts over the past three months, the overall consensus is Strong sell.

Strong buy
1
Buy
3
Hold
6
Sell
24
Strong sell
11

よくあるご質問

How has DRUG's EPS performed recently?

DRUG's EPS is projected to reach -- CAD next quarter. Explore more Bright Minds Biosciences Inc. financial data and stay up to date on the company's latest developments on the DRUG stock details page.

What is the revenue forecast for DRUG next quarter?

Bright Minds Biosciences Inc.'s revenue is projected to reach -- CAD in the next quarter. You can view Bright Minds Biosciences Inc.'s revenue and earnings on the DRUG stock details page.

What is the price target for DRUG?

Based on analyst estimates, the most likely target price for DRUG over the next 12 months is 135.80 CAD, with a projected high of 153.19 CAD and a projected low of 101.73 CAD. To track whether this target is reached within the next year, you can view the DRUG stock price chart on the DRUG stock details page to check the current DRUG stock price, or follow the latest developments related to DRUG on the DRUG Stock News page.

What is the analyst rating for DRUG?

We collected ratings from 45 analysts who have evaluated DRUG stock over the past three months. Most analysts maintain a Strong sell outlook, and after aggregating all opinions, the overall consensus rating is Strong sell. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of DRUG stock in 2030?

Based on price forecasts and analyses of Bright Minds Biosciences Inc. from Wall Street analysts and major investment banks, DRUG is projected to trade between 217.32 CAD and 1086.60 CAD in 2030.

DRUG stock chart

DRUG stock details

DRUGの株価変動

最終取引日において、DRUG株式の終値は108.66 CADで、1日の価格変動は3.03%でした。

株式先物を取引

Bitgetについて

世界初のユニバーサル取引所(UEX)では、ユーザーは暗号資産だけでなく、株式、ETF、外国為替、金、現実資産(RWA)も取引できます。
詳細を見る
CSE/
DRUG stock price forecast
© 2026 Bitget